2013Zhongguo jiceng yiyaoRequires access

Control analysis between mifepristone and medroxyprogesterone in the treatment of patients with perimenopausal dysfunctional uterine bleeding

Haixia Yang

Open publisher page 0 citations

Abstract

Objective To compare the effect between mifepristone and medroxyprogesterone in the treatment of patients with perimenopausal dysfunctional uterine bleeding.Methods 90 patients with perimenopausal dysfunctional uterine bleeding were randomly divided into two groups after diagnostic curettage surgery,the control group (n =45 cases) and the observation group(n =45 cases).The patients in the control group were treated with medroxyprogesterone,while the patients in the treatment group were treated with mifepristone.The endometrial thickness,anemia and menstrual flow were analyzed after three months.Results The total efficient rates were 71.1% in the control group and 88.9% in the observation group.There was a significant difference between two groups (P < 0.01).The endometrial thickness,anemia and menstrual flow were improved after treatment in both groups,which were more significantly improved in the treatment group (P < 0.05).Conclusion The mifepristone is significantly better than medroxyprogesterone acetate tablets in the control perimenopausal dysfunctional uterine bleeding. Key words: Dysfunctional uterine bleeding;  Perimenopausal;  Mifepristone;  Medroxyprogesterone

About this research paper

What this paper is about

Objective To compare the effect between mifepristone and medroxyprogesterone in the treatment of patients with perimenopausal dysfunctional uterine bleeding.Methods 90 patients with perimenopausal dysfunctional uterine bleeding were randomly divided into two groups after diagnostic curettage surgery,the control group (n =45 cases) and the observation group(n =45 cases).The patients in the control group were treated with medroxyprogesterone,while the patients in the treatment group were treated with mifepristone.The endometrial thickness,anemia and menstrual flow were analyzed after three months.Results The total efficient rates were 71.1% in the control group and 88.9% in the observation group.There was a significant difference between two groups (P < 0.01).The endometrial thickness,anemia and menstrual flow were improved after treatment in both groups,which were more significantly improved in the treatment group (P < 0.05).Conclusion The mifepristone is significantly better than medroxyprogesterone acetate tablets in the control perimenopausal dysfunctional uterine bleeding. Key words: Dysfunctional uterine bleeding;  Perimenopausal;  Mifepristone;  Medroxyprogesterone

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To compare the effect between mifepristone and medroxyprogesterone in the treatment of patients with perimenopausal dysfunctional uterine bleeding.Methods 90 patients with perimenopausal dysfunctional uterine bleeding were randomly divided into two groups after diagnostic curettage surgery,the control group (n =45 cases) and the observation group(n =45 cases).The patients in the control group were treated with medroxyprogesterone,while the patients in the treatment group were treated with mifepristone.The endometrial thickness,anemia and menstrual flow were analyzed after three months.Results The total efficient rates were 71.1% in the control group and 88.9% in the observation group.There was a significant difference between two groups (P < 0.01).The endometrial thickness,anemia and menstrual flow were improved after treatment in both groups,which were more significantly improved in the treatment group (P < 0.05).Conclusion The mifepristone is significantly better than medroxyprogesterone acetate tablets in the control perimenopausal dysfunctional uterine bleeding. Key words: Dysfunctional uterine bleeding;  Perimenopausal;  Mifepristone;  Medroxyprogesterone

Key concepts: Dysfunctional uterine bleeding, Medicine, Mifepristone, Medroxyprogesterone, Medroxyprogesterone acetate, Gynecology, Curettage, Endometrium

Related papers

Back to paper searchBrowse research topicsOriginal source
Control analysis between mifepristone and medroxyprogesterone in the treatment of patients with perimenopausal dysfunctional uterine bleeding — Research Paper | ScholarLens